Request Demo
Last update 11 Dec 2025
Yangzhengxiaoji Capsule
Last update 11 Dec 2025
Overview
Basic Info
Drug Type Herbal medicine |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (18 Mar 2020), |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with Yangzhengxiaoji CapsuleCTR20254356
养正消积胶囊治疗恶性肿瘤（非小细胞肺癌、胃癌、结直肠癌）癌因性疲乏有效性和安全性的随机、双盲、安慰剂平行对照Ⅱa期临床研究
[Translation] A randomized, double-blind, placebo-controlled phase IIa clinical trial to investigate the efficacy and safety of Yangzheng Xiaoji Capsules in treating cancer-related fatigue caused by malignant tumors (non-small cell lung cancer, gastric cancer, and colorectal cancer).
NCT02195453
A Randomized,Double-blind,Placebo-Controlled,Multicenter Clinical Trail of Chemotherapy Combined With Yangzhengxiaoji Capsule in Patients With Advanced Non-Small Cell Lung Cancer
NCT01949818
A Randomized, Controlled Mutiple-center Clinical Research on the Treatment With Yangzhengxiaoji Capsule Combination Chemotherapy for III/IV Diffuse Large B Cell Lymphoma
100 Clinical Results associated with Yangzhengxiaoji Capsule
Login to view more data
100 Translational Medicine associated with Yangzhengxiaoji Capsule
Login to view more data
100 Patents (Medical) associated with Yangzhengxiaoji Capsule
Login to view more data
100 Deals associated with Yangzhengxiaoji Capsule
Login to view more data
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Signs and Symptoms, Digestive | China | 18 Mar 2020 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colorectal Cancer | Phase 2 | China | 10 Nov 2025 | |
| Fatigue | Phase 2 | China | 10 Nov 2025 | |
| Non-Small Cell Lung Cancer | Phase 2 | China | 10 Nov 2025 | |
| Stomach Cancer | Phase 2 | China | 10 Nov 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free